The global rapid acting insulin market was valued at $7,100 million in 2019, and is projected to reach $8,925 million by 2027 at a CAGR of 4.1% from 2020 to 2027. The growth of the global rapid acting ...

Indian regulator Central Drugs Standard Control Organisation (CDSCO) has approved Cipla to exclusively distribute and market inhaled insulin in the country, the drugmaker said on Wednesday. The ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin ... as a biosimilar under the name Insulin lispro Sanofi ...

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

Administering insulin can bring your blood sugar levels down. It’s important to talk with a doctor about how much rapid-acting insulin you should administer when your blood sugar is high.

Some diabetes patients in the U.S. have this year pushed back against the company's decision to stop selling its long-acting insulin Levemir, which is an analogue insulin. They say the move has ...

Rel­ma­da Ther­a­peu­tics said Wednes­day morn­ing that a Phase 3 study test­ing its ma­jor de­pres­sion drug, REL-1017, is like­ly to fail, cra­ter­ing its stock price. … ...